P08 INTRA-OPERATIVE MRI: THE ALDER HEY EXPERIENCE SO FAR

INTRODUCTION: Intra-operative MRI (ioMRI) is increasingly being used by some neurosurgical units to ensure maximal tumour resection and therefore improved outcome. Its use has also extended to other non-oncological neurosurgical procedures. METHOD: We report our ioMRI experience in Alder Hey over a...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Neuro-oncology (Charlottesville, Va.) Va.), 2014-10, Vol.16 (suppl 6), p.vi2-vi2
Hauptverfasser: Zebian, B., Stagno, V., Parks, C. J., Pettorini, B., Mallucci, C., Pizer, B., Abernethy, L., Avula, S.
Format: Artikel
Sprache:eng
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page vi2
container_issue suppl 6
container_start_page vi2
container_title Neuro-oncology (Charlottesville, Va.)
container_volume 16
creator Zebian, B.
Stagno, V.
Parks, C. J.
Pettorini, B.
Mallucci, C.
Pizer, B.
Abernethy, L.
Avula, S.
description INTRODUCTION: Intra-operative MRI (ioMRI) is increasingly being used by some neurosurgical units to ensure maximal tumour resection and therefore improved outcome. Its use has also extended to other non-oncological neurosurgical procedures. METHOD: We report our ioMRI experience in Alder Hey over a period of 53 months and compare the results with a historical cohort prior to the introduction of ioMRI specifically looking at the group of patients where complete surgical tumour resection was the desired outcome. RESULTS: ioMRI was used in 183 cases since its introduction at Alder Hey. Of these, 143 were debulkings / resections of tumours, 6 biopsies, 1 cyst drainage, 25 epilepsy cases, 7 craniofacial and 1 abscess drainage. Approximately 30% of patients underwent second-look surgery following ioMRI. None have required return to theatre for resection of residual disease. This compares to 14% in the historical cohort prior to availability of ioMRI. There was no increase in morbidity - infection or otherwise - directly attributable to ioMRI. CONCLUSION: The use of ioMRI has proven to be safe and effective at ensuring that the goals of surgery are met and has allowed for an improved service by reducing return to theatre rates.
doi_str_mv 10.1093/neuonc/nou249.8
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1808705179</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1808705179</sourcerecordid><originalsourceid>FETCH-LOGICAL-c1148-7dcd2ed4ae3817164f31743b6102b79ff17b9bf9f3e91128f8247c4dcfe38c073</originalsourceid><addsrcrecordid>eNotkDFPwzAUhC0EEqUws3pkSetnO7HNFhWXRiptFQKCyUocWypqkxKTgX9PIEx30t096X0I3QKZAVFs3ri-bey8aXvK1UyeoQnElEWxTJLzP08jGYO4RFchfBBCIU5gguSOSJxtijyNtjudp0X2qvFTnt3jYqVxun7QOV7pd6zfhjTTm4XGz1u8TPNrdOHLQ3A3_zpFL0tdLFbRevuYLdJ1ZAG4jERta-pqXjomQUDCPQPBWZUAoZVQ3oOoVOWVZ04BUOkl5cLy2vphYIlgU3Q33j117Wfvwpc57oN1h0PZuLYPBiSRggyPqaE6H6u2a0PonDenbn8su28DxPwyMiMjMzIykv0AHQNV9Q</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1808705179</pqid></control><display><type>article</type><title>P08 INTRA-OPERATIVE MRI: THE ALDER HEY EXPERIENCE SO FAR</title><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>Oxford University Press Journals All Titles (1996-Current)</source><source>PubMed Central</source><creator>Zebian, B. ; Stagno, V. ; Parks, C. J. ; Pettorini, B. ; Mallucci, C. ; Pizer, B. ; Abernethy, L. ; Avula, S.</creator><creatorcontrib>Zebian, B. ; Stagno, V. ; Parks, C. J. ; Pettorini, B. ; Mallucci, C. ; Pizer, B. ; Abernethy, L. ; Avula, S.</creatorcontrib><description>INTRODUCTION: Intra-operative MRI (ioMRI) is increasingly being used by some neurosurgical units to ensure maximal tumour resection and therefore improved outcome. Its use has also extended to other non-oncological neurosurgical procedures. METHOD: We report our ioMRI experience in Alder Hey over a period of 53 months and compare the results with a historical cohort prior to the introduction of ioMRI specifically looking at the group of patients where complete surgical tumour resection was the desired outcome. RESULTS: ioMRI was used in 183 cases since its introduction at Alder Hey. Of these, 143 were debulkings / resections of tumours, 6 biopsies, 1 cyst drainage, 25 epilepsy cases, 7 craniofacial and 1 abscess drainage. Approximately 30% of patients underwent second-look surgery following ioMRI. None have required return to theatre for resection of residual disease. This compares to 14% in the historical cohort prior to availability of ioMRI. There was no increase in morbidity - infection or otherwise - directly attributable to ioMRI. CONCLUSION: The use of ioMRI has proven to be safe and effective at ensuring that the goals of surgery are met and has allowed for an improved service by reducing return to theatre rates.</description><identifier>ISSN: 1522-8517</identifier><identifier>EISSN: 1523-5866</identifier><identifier>DOI: 10.1093/neuonc/nou249.8</identifier><language>eng</language><ispartof>Neuro-oncology (Charlottesville, Va.), 2014-10, Vol.16 (suppl 6), p.vi2-vi2</ispartof><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27922,27923</link.rule.ids></links><search><creatorcontrib>Zebian, B.</creatorcontrib><creatorcontrib>Stagno, V.</creatorcontrib><creatorcontrib>Parks, C. J.</creatorcontrib><creatorcontrib>Pettorini, B.</creatorcontrib><creatorcontrib>Mallucci, C.</creatorcontrib><creatorcontrib>Pizer, B.</creatorcontrib><creatorcontrib>Abernethy, L.</creatorcontrib><creatorcontrib>Avula, S.</creatorcontrib><title>P08 INTRA-OPERATIVE MRI: THE ALDER HEY EXPERIENCE SO FAR</title><title>Neuro-oncology (Charlottesville, Va.)</title><description>INTRODUCTION: Intra-operative MRI (ioMRI) is increasingly being used by some neurosurgical units to ensure maximal tumour resection and therefore improved outcome. Its use has also extended to other non-oncological neurosurgical procedures. METHOD: We report our ioMRI experience in Alder Hey over a period of 53 months and compare the results with a historical cohort prior to the introduction of ioMRI specifically looking at the group of patients where complete surgical tumour resection was the desired outcome. RESULTS: ioMRI was used in 183 cases since its introduction at Alder Hey. Of these, 143 were debulkings / resections of tumours, 6 biopsies, 1 cyst drainage, 25 epilepsy cases, 7 craniofacial and 1 abscess drainage. Approximately 30% of patients underwent second-look surgery following ioMRI. None have required return to theatre for resection of residual disease. This compares to 14% in the historical cohort prior to availability of ioMRI. There was no increase in morbidity - infection or otherwise - directly attributable to ioMRI. CONCLUSION: The use of ioMRI has proven to be safe and effective at ensuring that the goals of surgery are met and has allowed for an improved service by reducing return to theatre rates.</description><issn>1522-8517</issn><issn>1523-5866</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2014</creationdate><recordtype>article</recordtype><recordid>eNotkDFPwzAUhC0EEqUws3pkSetnO7HNFhWXRiptFQKCyUocWypqkxKTgX9PIEx30t096X0I3QKZAVFs3ri-bey8aXvK1UyeoQnElEWxTJLzP08jGYO4RFchfBBCIU5gguSOSJxtijyNtjudp0X2qvFTnt3jYqVxun7QOV7pd6zfhjTTm4XGz1u8TPNrdOHLQ3A3_zpFL0tdLFbRevuYLdJ1ZAG4jERta-pqXjomQUDCPQPBWZUAoZVQ3oOoVOWVZ04BUOkl5cLy2vphYIlgU3Q33j117Wfvwpc57oN1h0PZuLYPBiSRggyPqaE6H6u2a0PonDenbn8su28DxPwyMiMjMzIykv0AHQNV9Q</recordid><startdate>20141001</startdate><enddate>20141001</enddate><creator>Zebian, B.</creator><creator>Stagno, V.</creator><creator>Parks, C. J.</creator><creator>Pettorini, B.</creator><creator>Mallucci, C.</creator><creator>Pizer, B.</creator><creator>Abernethy, L.</creator><creator>Avula, S.</creator><scope>AAYXX</scope><scope>CITATION</scope><scope>7TK</scope></search><sort><creationdate>20141001</creationdate><title>P08 INTRA-OPERATIVE MRI: THE ALDER HEY EXPERIENCE SO FAR</title><author>Zebian, B. ; Stagno, V. ; Parks, C. J. ; Pettorini, B. ; Mallucci, C. ; Pizer, B. ; Abernethy, L. ; Avula, S.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c1148-7dcd2ed4ae3817164f31743b6102b79ff17b9bf9f3e91128f8247c4dcfe38c073</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2014</creationdate><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Zebian, B.</creatorcontrib><creatorcontrib>Stagno, V.</creatorcontrib><creatorcontrib>Parks, C. J.</creatorcontrib><creatorcontrib>Pettorini, B.</creatorcontrib><creatorcontrib>Mallucci, C.</creatorcontrib><creatorcontrib>Pizer, B.</creatorcontrib><creatorcontrib>Abernethy, L.</creatorcontrib><creatorcontrib>Avula, S.</creatorcontrib><collection>CrossRef</collection><collection>Neurosciences Abstracts</collection><jtitle>Neuro-oncology (Charlottesville, Va.)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Zebian, B.</au><au>Stagno, V.</au><au>Parks, C. J.</au><au>Pettorini, B.</au><au>Mallucci, C.</au><au>Pizer, B.</au><au>Abernethy, L.</au><au>Avula, S.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>P08 INTRA-OPERATIVE MRI: THE ALDER HEY EXPERIENCE SO FAR</atitle><jtitle>Neuro-oncology (Charlottesville, Va.)</jtitle><date>2014-10-01</date><risdate>2014</risdate><volume>16</volume><issue>suppl 6</issue><spage>vi2</spage><epage>vi2</epage><pages>vi2-vi2</pages><issn>1522-8517</issn><eissn>1523-5866</eissn><abstract>INTRODUCTION: Intra-operative MRI (ioMRI) is increasingly being used by some neurosurgical units to ensure maximal tumour resection and therefore improved outcome. Its use has also extended to other non-oncological neurosurgical procedures. METHOD: We report our ioMRI experience in Alder Hey over a period of 53 months and compare the results with a historical cohort prior to the introduction of ioMRI specifically looking at the group of patients where complete surgical tumour resection was the desired outcome. RESULTS: ioMRI was used in 183 cases since its introduction at Alder Hey. Of these, 143 were debulkings / resections of tumours, 6 biopsies, 1 cyst drainage, 25 epilepsy cases, 7 craniofacial and 1 abscess drainage. Approximately 30% of patients underwent second-look surgery following ioMRI. None have required return to theatre for resection of residual disease. This compares to 14% in the historical cohort prior to availability of ioMRI. There was no increase in morbidity - infection or otherwise - directly attributable to ioMRI. CONCLUSION: The use of ioMRI has proven to be safe and effective at ensuring that the goals of surgery are met and has allowed for an improved service by reducing return to theatre rates.</abstract><doi>10.1093/neuonc/nou249.8</doi><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1522-8517
ispartof Neuro-oncology (Charlottesville, Va.), 2014-10, Vol.16 (suppl 6), p.vi2-vi2
issn 1522-8517
1523-5866
language eng
recordid cdi_proquest_miscellaneous_1808705179
source Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; Oxford University Press Journals All Titles (1996-Current); PubMed Central
title P08 INTRA-OPERATIVE MRI: THE ALDER HEY EXPERIENCE SO FAR
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-09T19%3A17%3A33IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=P08%20INTRA-OPERATIVE%20MRI:%20THE%20ALDER%20HEY%20EXPERIENCE%20SO%20FAR&rft.jtitle=Neuro-oncology%20(Charlottesville,%20Va.)&rft.au=Zebian,%20B.&rft.date=2014-10-01&rft.volume=16&rft.issue=suppl%206&rft.spage=vi2&rft.epage=vi2&rft.pages=vi2-vi2&rft.issn=1522-8517&rft.eissn=1523-5866&rft_id=info:doi/10.1093/neuonc/nou249.8&rft_dat=%3Cproquest_cross%3E1808705179%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1808705179&rft_id=info:pmid/&rfr_iscdi=true